China SXT Pharmaceuticals (SXTC) Competitors $1.46 +0.01 (+0.97%) Closing price 10/15/2025 03:50 PM EasternExtended Trading$1.44 -0.02 (-1.30%) As of 10/15/2025 07:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock SXTC vs. MLTX, GLUE, CMPS, SNDL, KOD, MGTX, KROS, ARCT, ZVRA, and MNPRShould you be buying China SXT Pharmaceuticals stock or one of its competitors? The main competitors of China SXT Pharmaceuticals include MoonLake Immunotherapeutics (MLTX), Monte Rosa Therapeutics (GLUE), COMPASS Pathways (CMPS), SNDL (SNDL), Kodiak Sciences (KOD), MeiraGTx (MGTX), Keros Therapeutics (KROS), Arcturus Therapeutics (ARCT), Zevra Therapeutics (ZVRA), and Monopar Therapeutics (MNPR). These companies are all part of the "pharmaceutical products" industry. China SXT Pharmaceuticals vs. Its Competitors MoonLake Immunotherapeutics Monte Rosa Therapeutics COMPASS Pathways SNDL Kodiak Sciences MeiraGTx Keros Therapeutics Arcturus Therapeutics Zevra Therapeutics Monopar Therapeutics China SXT Pharmaceuticals (NASDAQ:SXTC) and MoonLake Immunotherapeutics (NASDAQ:MLTX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings. Does the media refer more to SXTC or MLTX? In the previous week, MoonLake Immunotherapeutics had 29 more articles in the media than China SXT Pharmaceuticals. MarketBeat recorded 31 mentions for MoonLake Immunotherapeutics and 2 mentions for China SXT Pharmaceuticals. China SXT Pharmaceuticals' average media sentiment score of 0.83 beat MoonLake Immunotherapeutics' score of 0.31 indicating that China SXT Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment China SXT Pharmaceuticals 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MoonLake Immunotherapeutics 5 Very Positive mention(s) 3 Positive mention(s) 21 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is SXTC or MLTX more profitable? China SXT Pharmaceuticals' return on equity of 0.00% beat MoonLake Immunotherapeutics' return on equity.Company Net Margins Return on Equity Return on Assets China SXT PharmaceuticalsN/A N/A N/A MoonLake Immunotherapeutics N/A -40.98%-35.81% Do analysts recommend SXTC or MLTX? MoonLake Immunotherapeutics has a consensus price target of $36.00, suggesting a potential upside of 264.00%. Given MoonLake Immunotherapeutics' stronger consensus rating and higher probable upside, analysts plainly believe MoonLake Immunotherapeutics is more favorable than China SXT Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score China SXT Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00MoonLake Immunotherapeutics 2 Sell rating(s) 9 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.07 Do insiders and institutionals have more ownership in SXTC or MLTX? 5.0% of China SXT Pharmaceuticals shares are held by institutional investors. Comparatively, 93.9% of MoonLake Immunotherapeutics shares are held by institutional investors. 4.0% of China SXT Pharmaceuticals shares are held by company insiders. Comparatively, 12.0% of MoonLake Immunotherapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more risk & volatility, SXTC or MLTX? China SXT Pharmaceuticals has a beta of 1.36, meaning that its share price is 36% more volatile than the S&P 500. Comparatively, MoonLake Immunotherapeutics has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. Which has higher valuation & earnings, SXTC or MLTX? China SXT Pharmaceuticals has higher revenue and earnings than MoonLake Immunotherapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChina SXT Pharmaceuticals$1.74M97.57-$3.30MN/AN/AMoonLake ImmunotherapeuticsN/AN/A-$118.94M-$2.78-3.56 SummaryChina SXT Pharmaceuticals and MoonLake Immunotherapeutics tied by winning 6 of the 12 factors compared between the two stocks. Get China SXT Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SXTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SXTC vs. The Competition Export to ExcelMetricChina SXT PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$168.24M$2.96B$6.12B$10.45BDividend YieldN/A57.77%5.73%4.77%P/E RatioN/A22.7985.3327.36Price / Sales97.57778.19601.99136.95Price / CashN/A172.6337.4661.86Price / Book0.075.5112.566.81Net Income-$3.30M$33.06M$3.32B$276.80M7 Day Performance-5.55%0.23%0.59%0.42%1 Month Performance-21.50%14.73%10.52%7.86%1 Year Performance-69.55%-1.42%75.05%41.24% China SXT Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SXTCChina SXT Pharmaceuticals0.4989 of 5 stars$1.46+1.0%N/A-71.1%$168.24M$1.74M0.0090Gap DownMLTXMoonLake Immunotherapeutics2.9167 of 5 stars$10.26-3.7%$36.00+250.8%-79.4%$654.83MN/A-3.672Trending NewsGap UpGLUEMonte Rosa Therapeutics2.6883 of 5 stars$10.52+1.1%$15.33+45.8%+117.0%$646.81M$75.62M29.0990CMPSCOMPASS Pathways3.2289 of 5 stars$6.75+7.3%$16.00+137.1%+15.0%$645.96MN/A-3.66120News CoverageAnalyst ForecastSNDLSNDL3.3051 of 5 stars$2.46-1.0%$4.50+83.3%+25.9%$645.13M$671.81M-9.092,516News CoverageKODKodiak Sciences3.079 of 5 stars$12.00+3.4%$13.20+10.0%+416.7%$636.75MN/A-3.1790MGTXMeiraGTx4.1583 of 5 stars$7.86+0.3%$24.00+205.5%+52.7%$631.21M$33.28M-3.85300KROSKeros Therapeutics2.7739 of 5 stars$15.29-3.8%$30.00+96.2%-76.0%$620.88M$3.55M49.31100News CoverageInsider TradeARCTArcturus Therapeutics3.0523 of 5 stars$22.07+13.8%$50.57+129.2%+2.9%$597.71M$152.31M-9.87180Analyst UpgradeZVRAZevra Therapeutics2.6236 of 5 stars$10.54-1.4%$24.00+127.6%+40.6%$591.61M$23.61M-50.1920Analyst ForecastMNPRMonopar Therapeutics2.7073 of 5 stars$96.68-5.3%$105.67+9.3%+1,655.7%$591.12MN/A-28.7710Analyst Forecast Related Companies and Tools Related Companies MoonLake Immunotherapeutics Alternatives Monte Rosa Therapeutics Alternatives COMPASS Pathways Alternatives SNDL Alternatives Kodiak Sciences Alternatives MeiraGTx Alternatives Keros Therapeutics Alternatives Arcturus Therapeutics Alternatives Zevra Therapeutics Alternatives Monopar Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SXTC) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China SXT Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China SXT Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
